Last reviewed · How we verify
Tardive dyskinesia
Approved treatments
- Ingrezza · Neurocrine
- Austedo · Teva
Austedo works by binding to the synaptic vesicular amine transporter, reducing the release of dopamine and other neurotransmitters.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Tardive dyskinesia patent landscape — cliff calendar, originator estates, attackable patents
- Tardive dyskinesia treatment landscape brief
- Tardive dyskinesia treatment updates RSS
Frequently asked questions about Tardive dyskinesia
What drugs treat Tardive dyskinesia?
Tracked treatments include Ingrezza, Austedo.
What is the treatment for Tardive dyskinesia?
Standard treatment for Tardive dyskinesia includes Ingrezza, Austedo. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Tardive dyskinesia patent cliff · Tardive dyskinesia CI report
- Treatment: Ingrezza · Neurocrine
- Treatment: Austedo · Teva
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing